V116 Elicits Noninferiority Immune Response Compared with PPSV23 for Pneumococcal Disease
Merck presented results from the STRIDE-10 phase 3 trial at the 34th European Society of Clinical Microbiology and Infectious Diseases in Barcelona, Spain.
Comunidad Autonoma De Cataluna South Africa Cape Town Western Cape Bernard Chantal European Society Of Clinical Microbiology
Source: pharmacytimes.com